These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30116012)

  • 1. Effect of MBOAT7 variant on hepatitis B and C infections in Moroccan patients.
    Ezzikouri S; Elfihry R; Chihab H; Elmessaoudi-Idrissi M; Zaidane I; Jadid FZ; Karami A; Tahiri M; Elhabazi A; Kabine M; Chair M; Pineau P; Benjelloun S
    Sci Rep; 2018 Aug; 8(1):12247. PubMed ID: 30116012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-bound O-acyltransferase domain-containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B.
    Thabet K; Chan HLY; Petta S; Mangia A; Berg T; Boonstra A; Brouwer WP; Abate ML; Wong VW; Nazmy M; Fischer J; Liddle C; George J; Eslam M
    Hepatology; 2017 Jun; 65(6):1840-1850. PubMed ID: 28109005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the association of a variant in PNPLA3 and TM6SF2 with fibrosis progression in patients with chronic hepatitis C infection after eradication: A retrospective study.
    Kang Q; Xu J; Luo H; Tan N; Chen H; Cheng R; Pan J; Han Y; Yang Y; Liu D; Xi H; Yu M; Xu X
    Gene; 2022 Apr; 820():146235. PubMed ID: 35143946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C.
    Thabet K; Asimakopoulos A; Shojaei M; Romero-Gomez M; Mangia A; Irving WL; Berg T; Dore GJ; Grønbæk H; Sheridan D; Abate ML; Bugianesi E; Weltman M; Mollison L; Cheng W; Riordan S; Fischer J; Spengler U; Nattermann J; Wahid A; Rojas A; White R; Douglas MW; McLeod D; Powell E; Liddle C; van der Poorten D; George J; Eslam M;
    Nat Commun; 2016 Sep; 7():12757. PubMed ID: 27630043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mutation of the HFE gene on the progression of chronic viral hepatitis B and C in Moroccan patients.
    Ezzikouri S; Rebbani K; Mostafa A; El Feydi AE; Afifi R; Brahim I; Kitab B; Benazzouz M; Kandil M; Nadifi S; Pineau P; Benjelloun S
    J Med Virol; 2011 Dec; 83(12):2096-102. PubMed ID: 22012716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxovirus resistance 1 gene polymorphisms and outcomes of viral hepatitis B and C infections in Moroccan patients.
    Rebbani K; Ababou M; Nadifi S; Kandil M; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
    J Med Virol; 2017 Apr; 89(4):647-652. PubMed ID: 27458866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children.
    Zusi C; Morandi A; Maguolo A; Corradi M; Costantini S; Mosca A; Crudele A; Mantovani A; Alisi A; Miraglia Del Giudice E; Targher G; Maffeis C
    Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1548-1555. PubMed ID: 33810963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.
    Di Sessa A; Umano GR; Cirillo G; Del Prete A; Iacomino R; Marzuillo P; Del Giudice EM
    J Pediatr Gastroenterol Nutr; 2018 Jul; 67(1):69-74. PubMed ID: 29601441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.
    Mancina RM; Dongiovanni P; Petta S; Pingitore P; Meroni M; Rametta R; Borén J; Montalcini T; Pujia A; Wiklund O; Hindy G; Spagnuolo R; Motta BM; Pipitone RM; Craxì A; Fargion S; Nobili V; Käkelä P; Kärjä V; Männistö V; Pihlajamäki J; Reilly DF; Castro-Perez J; Kozlitina J; Valenti L; Romeo S
    Gastroenterology; 2016 May; 150(5):1219-1230.e6. PubMed ID: 26850495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals.
    Donati B; Dongiovanni P; Romeo S; Meroni M; McCain M; Miele L; Petta S; Maier S; Rosso C; De Luca L; Vanni E; Grimaudo S; Romagnoli R; Colli F; Ferri F; Mancina RM; Iruzubieta P; Craxi A; Fracanzani AL; Grieco A; Corradini SG; Aghemo A; Colombo M; Soardo G; Bugianesi E; Reeves H; Anstee QM; Fargion S; Valenti L
    Sci Rep; 2017 Jul; 7(1):4492. PubMed ID: 28674415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and additive effects of PNPLA3 and TM6SF2 polymorphisms on the development of non-B, non-C hepatocellular carcinoma.
    Raksayot M; Chuaypen N; Khlaiphuengsin A; Pinjaroen N; Treeprasertsuk S; Poovorawan Y; Tanaka Y; Tangkijvanich P
    J Gastroenterol; 2019 May; 54(5):427-436. PubMed ID: 30506232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children.
    Lin YC; Chang PF; Chang MH; Ni YH
    Liver Int; 2018 Jul; 38(7):1300-1307. PubMed ID: 29314568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MBOAT7 rs641738 variant is associated with an improved outcome in primary sclerosing cholangitis.
    Freund C; Wahlers A; Begli NH; Leopold Y; Klöters-Plachky P; Mehrabi A; Mohr I; Sander J; Rupp C; Gotthardt DN; Weiss KH
    Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):646-652. PubMed ID: 31928970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study.
    Krawczyk M; Rau M; Schattenberg JM; Bantel H; Pathil A; Demir M; Kluwe J; Boettler T; Lammert F; Geier A;
    J Lipid Res; 2017 Jan; 58(1):247-255. PubMed ID: 27836992
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Wang P; Li Y; Li L; Zhong R; Shen N
    Front Oncol; 2021; 11():639438. PubMed ID: 34113561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence supporting a role of TMC4-rs641738 missense variant-MBOAT7- intergenic downstream variant-in the Susceptibility to Nonalcoholic Fatty Liver Disease.
    Sookoian S; Flichman D; Garaycoechea ME; Gazzi C; Martino JS; Castaño GO; Pirola CJ
    Sci Rep; 2018 Mar; 8(1):5097. PubMed ID: 29572551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of hepatic Mboat7 leads to liver fibrosis.
    Thangapandi VR; Knittelfelder O; Brosch M; Patsenker E; Vvedenskaya O; Buch S; Hinz S; Hendricks A; Nati M; Herrmann A; Rekhade DR; Berg T; Matz-Soja M; Huse K; Klipp E; Pauling JK; Wodke JA; Miranda Ackerman J; Bonin MV; Aigner E; Datz C; von Schönfels W; Nehring S; Zeissig S; Röcken C; Dahl A; Chavakis T; Stickel F; Shevchenko A; Schafmayer C; Hampe J; Subramanian P
    Gut; 2021 May; 70(5):940-950. PubMed ID: 32591434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Investigation of the association between chronic hepatitis B and C infections and TNF-α (-308) gene polymorphism].
    Börekçi G; Aras N; Kandemir Ö; Yalın S; Karakaş Çelik S; Berköz M
    Mikrobiyol Bul; 2016 Apr; 50(2):236-44. PubMed ID: 27175496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MBOAT7 rs641738 Variant Is Not Associated with an Increased Risk of Hepatocellular Carcinoma in a Latin American Cohort.
    Goble S; Akambase J; Prieto J; Balderramo D; Ferrer JD; Mattos AZ; Arrese M; Carrera E; Groothuismink ZMA; Oliveira J; Boonstra A; Debes JD
    Dig Dis Sci; 2023 Nov; 68(11):4212-4220. PubMed ID: 37684433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection.
    Coppola N; Marrone A; Pisaturo M; Starace M; Signoriello G; Gentile I; Adinolfi LE; Sagnelli E; Zampino R
    Eur J Clin Microbiol Infect Dis; 2014 Apr; 33(4):559-67. PubMed ID: 24081499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.